Duodenal Ulcer
📧 Sign up to get email alerts when something new happens for Duodenal Ulcer.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-08-20FDA Approved: LANSOPRAZOLE — Supplemental Application (Xiromed LLC)
FDA approved a supplemental application for lansoprazole by Xiromed LLC, indicating an approved update to an already-approved product (such …
-
CLINICAL_TRIALS trial_result · 2020-08-07Clinical Trial Update: A Phase 2 Randomised Controlled Trial to Evaluate Efficacy and Safety of Anaprazole in Patients With Duodenal Ulcers. [Phase 2]
A Phase 2 randomized trial evaluated the efficacy and safety of Anaprazole in patients with duodenal ulcers; study completed.
-
FDA approval · 2020-06-30FDA Approved: PANTOPRAZOLE SODIUM — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Pantoprazole sodium as a generic pantoprazole product under an original application by Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2020-06-25FDA Approved: ACID REDUCER — Original Application (CVS Pharmacy)
The FDA approved CVS Pharmacy's original application for a generic esomeprazole magnesium product (ACID REDUCER), expanding access to proton…
-
FDA approval · 2020-06-23FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Civica, Inc.)
The FDA approved a supplemental application for pantoprazole sodium submitted by Civica, Inc. with this action representing an approved supp…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-06-12Clinical Trial Update: Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Duodenal Ulcer Participants With or Without Helicobacter Pylori Infection [Phase 3]
Phase 3 trial comparing TAK-438 (Vonoprazan) to Lansoprazole in duodenal ulcer treatment, with or without Helicobacter pylori infection; stu…
-
FDA approval · 2020-06-02FDA Approved: ESOMEPRAZOLE MAGNESIUM — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' esomeprazole magnesium as a generic product (Original Application), expanding access to a proton pump i…
-
FDA approval · 2020-06-02FDA Approved: ESOMEPRAZOLE MAGNESIUM — Original Application (Allegiant Health)
FDA approved Allegiant Health's esomeprazole magnesium delayed-release capsule as an original ANDA, providing a generic proton pump inhibito…
-
FDA approval · 2020-05-18FDA Approved: LANSOPRAZOLE — Original Application (Camber Pharmaceuticals, Inc.)
The FDA approved Camber Pharmaceuticals' original application for a generic lansoprazole product.
-
FDA approval · 2020-05-14FDA Approved: ESOMEPRAZOLE MAGNESIUM — Original Application (Dr. Reddys Laboratories Inc)
FDA approved an original-application generic esomeprazole magnesium from Dr. Reddy's Laboratories Inc.
-
FDA label_change · 2020-05-13FDA Approved: FAMOTIDINE — Supplemental Application (Carlsbad Technology, Inc)
FDA approved a supplemental application for famotidine (Carlsbad Technology, Inc.), resulting in changes to its labeling.
-
FDA approval · 2020-04-30FDA Approved: OMEPRAZOLE, SODIUM BICARBONATE — Original Application (Guardian Drug Company)
FDA approved Guardian Drug Company's original application for omeprazole sodium bicarbonate, a generic proton pump inhibitor combination, fo…
-
FDA approval · 2020-04-20FDA Approved: ESOMEPRAZOLE MAGNESIUM — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for esomeprazole magnesium (Ascend Laboratories) to bring a generic product to market.
-
FDA approval · 2020-04-01FDA Approved: ESOMEPRAZOLE SODIUM — Original Application (Gland Pharma Limited)
FDA approved the original application for esomeprazole sodium (generic) from Gland Pharma Limited, enabling its marketing in the United Stat…
-
FDA approval · 2020-03-25FDA Approved: OMEPRAZOLE — Original Application (CHAIN DRUG MARKETING ASSOCIATION, INC.)
The FDA approves an original application for omeprazole (generic) submitted by Chain Drug Marketing Association, Inc., covering indications …
-
FDA approval · 2020-03-23FDA Approved: ESOMEPRAZOLE MAGNESIUM — Original Application (Cipla USA Inc.)
The FDA approved Cipla USA Inc.'s original application for esomeprazole magnesium, a generic proton pump inhibitor.
-
FDA approval · 2020-03-23FDA Approved: ESOMEPRAZOLE MAGNESIUM — Original Application (Cipla USA Inc.)
The FDA approved Cipla USA Inc.'s Esomeprazole Magnesium as a generic version of esomeprazole under an Original Application (ANDA).
-
CLINICAL_TRIALS research · 2020-03-11Clinical Trial Update: Special Drug Use Surveillance of Vonoprazan for "Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin: Long-term Use"
A clinical trial update on vonoprazan for preventing recurrence of gastric/duodenal ulcers in patients on low-dose aspirin; study completed …
-
FDA approval · 2020-03-03FDA Approved: LANSOPRAZOLE — Supplemental Application (Lifestar Pharma LLC.)
FDA approves a supplemental application to allow Lifestar Pharma LLC to market a generic version of lansoprazole.
-
FDA approval · 2020-02-21FDA Approved: CIMETIDINE 200 ACID REDUCER — Supplemental Application (Walgreen Company)
The FDA approved a supplemental application for Walgreens' CIMETIDINE 200 ACID REDUCER, indicating approval of changes to the approved gener…
-
FDA label_change · 2020-01-07FDA Approved: FAMOTIDINE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA notes a supplemental application for famotidine by Lupin Pharmaceuticals, likely involving labeling changes for the drug.
-
FDA approval · 2020-01-03FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for pantoprazole sodium from Lannett Company (ANDA 078281).
-
CLINICAL_TRIALS trial_result · 2020-01-02Clinical Trial Update: A Phase 3 Randomised Controlled Trial to Evaluate Efficacy and Safety of Anaprazole in Patients With Duodenal Ulcers. [Phase 3]
A Phase 3 randomized trial evaluating the efficacy and safety of anaprazole for duodenal ulcers is ongoing with unknown status.
-
CLINICAL_TRIALS trial_result · 2019-12-12Clinical Trial Update: Drug Use Surveillance of Vonoprazan for "Gastric Ulcer, Duodenal Ulcer, and Reflux Esophagitis"
A completed clinical trial update for vonoprazan assessing gastric ulcer, duodenal ulcer, and reflux esophagitis with results posted in 2019…
-
FDA approval · 2019-12-02FDA Approved: SUCRALFATE — Original Application (AvPAK)
FDA approved the original ANDA for sucralfate oral, enabling generic marketing by AvPAK.